Nothing Special   »   [go: up one dir, main page]

DE69835322D1 - Neue tetralon-oder benzopyranon-derivate und ein verfahren zu ihrer herstellung - Google Patents

Neue tetralon-oder benzopyranon-derivate und ein verfahren zu ihrer herstellung

Info

Publication number
DE69835322D1
DE69835322D1 DE69835322T DE69835322T DE69835322D1 DE 69835322 D1 DE69835322 D1 DE 69835322D1 DE 69835322 T DE69835322 T DE 69835322T DE 69835322 T DE69835322 T DE 69835322T DE 69835322 D1 DE69835322 D1 DE 69835322D1
Authority
DE
Germany
Prior art keywords
group
benzopyranone
tetralone
derivatives
alkyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69835322T
Other languages
English (en)
Other versions
DE69835322T2 (de
Inventor
Makoto Yoshihama
Masamichi Nakakoshi
Junji Nakamura
Shoji Nakayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69835322D1 publication Critical patent/DE69835322D1/de
Publication of DE69835322T2 publication Critical patent/DE69835322T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/613Unsaturated compounds containing a keto groups being part of a ring polycyclic
    • C07C49/617Unsaturated compounds containing a keto groups being part of a ring polycyclic a keto group being part of a condensed ring system
    • C07C49/643Unsaturated compounds containing a keto groups being part of a ring polycyclic a keto group being part of a condensed ring system having three rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/687Unsaturated compounds containing a keto groups being part of a ring containing halogen
    • C07C49/697Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69835322T 1997-01-29 1998-01-28 Neue tetralon-oder benzopyranon-derivate und ein verfahren zu ihrer herstellung Expired - Fee Related DE69835322T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2825897 1997-01-29
JP2825897 1997-01-29
JP9225564A JPH10273467A (ja) 1997-01-29 1997-08-08 新規テトラロン又はベンゾピラノン誘導体及びその製造方法
JP22556497 1997-08-08
PCT/JP1998/000344 WO1998032724A1 (fr) 1997-01-29 1998-01-28 Nouveaux derives de tetralone ou de benzopyranone et procede de fabrication correspondant

Publications (2)

Publication Number Publication Date
DE69835322D1 true DE69835322D1 (de) 2006-09-07
DE69835322T2 DE69835322T2 (de) 2007-07-19

Family

ID=26366312

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69835322T Expired - Fee Related DE69835322T2 (de) 1997-01-29 1998-01-28 Neue tetralon-oder benzopyranon-derivate und ein verfahren zu ihrer herstellung

Country Status (14)

Country Link
US (1) US6080781A (de)
EP (1) EP0902003B1 (de)
JP (1) JPH10273467A (de)
KR (1) KR100304390B1 (de)
CN (1) CN1127470C (de)
AT (1) ATE334110T1 (de)
AU (1) AU717742B2 (de)
DE (1) DE69835322T2 (de)
ES (1) ES2270503T3 (de)
IL (1) IL126138A (de)
NO (1) NO311715B1 (de)
NZ (1) NZ331858A (de)
RU (1) RU2152379C1 (de)
WO (1) WO1998032724A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9929302D0 (en) * 1999-12-11 2000-02-02 Univ Cardiff Benzyl tetralins compositions and uses thereof
KR100436220B1 (ko) * 2001-08-30 2004-06-12 주식회사 네패스 바닥 반사방지막용 유기 중합체, 그의 제조방법 및 그를함유하는 조성물
US7754709B2 (en) 2003-06-10 2010-07-13 Solvay Pharmaceuticals Bv Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds
US7465739B2 (en) 2003-06-10 2008-12-16 Solvay Pharmaceuticals B.V. Compounds and their use in therapy
GB0513702D0 (en) 2005-07-04 2005-08-10 Sterix Ltd Compound
ATE537151T1 (de) * 2006-10-31 2011-12-15 Pfizer Prod Inc Pyrazolinverbindungen als mineralocorticoidrezeptorantagonisten
JP2009062300A (ja) * 2007-09-05 2009-03-26 Sumitomo Chemical Co Ltd クマリン化合物及びその用途
JP2009079039A (ja) * 2007-09-05 2009-04-16 Sumitomo Chemical Co Ltd クマリン化合物及びその用途
JP2009084269A (ja) * 2007-09-05 2009-04-23 Sumitomo Chemical Co Ltd クマリン化合物及びその用途
GB0722779D0 (en) 2007-11-20 2008-01-02 Sterix Ltd Compound
CN106278857A (zh) * 2016-08-26 2017-01-04 武汉理工大学 α,β‑不饱和羰基四氢萘酮衍生物及其应用
JP7296948B2 (ja) * 2017-09-07 2023-06-23 ニューソアラ バイオファーマ カンパニー リミテッド ベンゼン縮合複素環誘導体およびその医薬組成物
CN109574974A (zh) * 2019-01-21 2019-04-05 成都信立诺医药科技有限公司 苏木酮a的制备和纯化方法
CN111978281B (zh) * 2020-09-02 2023-03-28 河南师范大学 一种制备环己酮/色烯并吡喃酮类化合物的方法及其化合物应用
CN114230457B (zh) * 2022-01-04 2023-06-09 中山大学 一类2-亚苄基四氢萘酮衍生物及其制备方法和应用
CN115925665B (zh) * 2022-12-09 2024-06-25 中国药科大学 一种pde4抑制剂及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5414457B2 (de) * 1971-08-06 1979-06-07
BE788991A (fr) * 1971-09-20 1973-03-19 Lilly Co Eli Arylidene cyclanones et methode d'utilisation de celles-ci dansl'inhibition de l'action des androgenes
US3833726A (en) * 1971-12-13 1974-09-03 Warner Lambert Co 1-oxo-substituted-tetrahydronaphthalenes (substituted-tetralones)
US3843665A (en) * 1973-04-11 1974-10-22 Sandoz Ag Process for preparing substituted indeno,naphtho and cyclohepta pyrazoles
MX13485A (es) * 1987-10-19 1993-05-01 Pfizer Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos
GB9203497D0 (en) * 1992-02-19 1992-04-08 Lilly Industries Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
RU2152379C1 (ru) 2000-07-10
IL126138A0 (en) 1999-05-09
AU717742B2 (en) 2000-03-30
KR100304390B1 (ko) 2001-11-30
CN1127470C (zh) 2003-11-12
CN1216036A (zh) 1999-05-05
WO1998032724A1 (fr) 1998-07-30
DE69835322T2 (de) 2007-07-19
NO984532L (no) 1998-10-30
KR20000064631A (ko) 2000-11-06
NZ331858A (en) 1999-06-29
EP0902003A4 (de) 1999-06-09
NO311715B1 (no) 2002-01-14
US6080781A (en) 2000-06-27
JPH10273467A (ja) 1998-10-13
EP0902003A1 (de) 1999-03-17
NO984532D0 (no) 1998-09-28
ATE334110T1 (de) 2006-08-15
EP0902003B1 (de) 2006-07-26
AU5678498A (en) 1998-08-18
IL126138A (en) 2007-12-03
ES2270503T3 (es) 2007-04-01

Similar Documents

Publication Publication Date Title
DE69835322D1 (de) Neue tetralon-oder benzopyranon-derivate und ein verfahren zu ihrer herstellung
DE69532634D1 (de) Zwischenprodukte für die herstellung von pharmazeutischem camptothecin
DE69524251D1 (de) Neue verbindung, verfahren zu ihrer herstellung und antitumormittel
ATE229527T1 (de) Pyrazolopyridylpyrazinon-derivate und ein verfahren zu ihrer herstellung
ATE246180T1 (de) Benzofuranon-derivate und verfahren zu ihrer herstellung
ATE242241T1 (de) Imidazopyridinderivate und verfahren zu ihrer herstellung
ATE60060T1 (de) Sialosylceramide und verfahren zu deren herstellung.
ATE224379T1 (de) Ein verfahren zur herstellung von 1,4,7,10- tetraazacyclododecan-1,4,7-triessigsäure und deren derivaten
DE3864707D1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
ATE277887T1 (de) Verfahren zur herstellung von 1,4-bis((2- (dimethylamino)ethyl amino)-5,8- dihydroxyanthracene-9,10-dion
DE3770359D1 (de) 6-amino-anthracycline, verfahren zu ihrer herstellung und ihre verwendung.
DE69513408D1 (de) Ein verbessertes verfahren für die herstellung von seitenketten-derivaten von cyclohexapeptidyl-lipopeptiden
CA2250258A1 (en) Novel tetralone or benzopyranone derivatives and process for producing the same
ATE95177T1 (de) Naphthothiazepin-derivate und verfahren zu ihrer herstellung.
DE69814771D1 (de) Gamma-oxohomophenylalanin derivate und ein verfahren zur herstellung von homophenylalanin derivaten durch reduktion derselben
BR9910603A (pt) Método aprimorado paraa preparar derivados de norbenzomorfano valiosos farmaceuticamente
DE69819504D1 (de) Verfahren zur herstellung von 2-alkylthiobenzonitril-derivaten
DE60028998D1 (de) Verfahren zur herstellung einer benzylamin-verbindung
ATE307134T1 (de) Verfahren zur herstellung von decahydro-2a,4a,6a, 8a-tetraazacyclopent(fg)acenaphthylene und dessen funktionelle derivate
DE60321577D1 (de) Verfahren zu deren herstellung
ATE206109T1 (de) Verfahren zur herstellung von carbamoylmethylharnstoff-derivaten
DE3881458D1 (de) Verfahren zur herstellung von makrolid-derivaten.
ATE244228T1 (de) Verfahren zur herstellung von chloroacetylaminothiazoleaceticsäure derivate
HUP9803015A2 (hu) Eljárás dofetilid előállítására, közbenső termékei és eljárás azok előállítására

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee